Healthpeak Properties (NYSE:DOC) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says

Healthpeak Properties (NYSE:DOC) had its target price increased by stock analysts at Wells Fargo & Company from $20.00 to $22.00 in a research report issued on Wednesday,Benzinga reports. The firm currently has an “equal weight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s price objective indicates a potential upside of 1.40% from the company’s current price.

Other research analysts also recently issued research reports about the stock. Morgan Stanley restated an “equal weight” rating and set a $22.00 price objective (up from $20.00) on shares of Healthpeak Properties in a research report on Thursday, June 11th. Citigroup boosted their target price on shares of Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a research note on Tuesday, May 12th. Evercore cut Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price target on the stock. in a report on Monday, May 11th. UBS Group raised their price target on Healthpeak Properties from $19.00 to $21.50 and gave the stock a “neutral” rating in a research note on Wednesday, July 8th. Finally, Scotiabank upped their price objective on Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research report on Wednesday, May 27th. Four equities research analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $20.62.

Healthpeak Properties Price Performance

Shares of NYSE:DOC opened at $21.70 on Wednesday. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96. The firm has a market cap of $14.96 billion, a price-to-earnings ratio of 67.80, a price-to-earnings-growth ratio of 3.38 and a beta of 1.02. The business has a 50-day simple moving average of $20.31 and a two-hundred day simple moving average of $18.12. Healthpeak Properties has a fifty-two week low of $15.70 and a fifty-two week high of $22.13.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The firm had revenue of $752.95 million for the quarter, compared to the consensus estimate of $694.59 million. During the same quarter last year, the firm posted $0.46 EPS. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. On average, analysts expect that Healthpeak Properties will post 1.75 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the transaction, the insider directly owned 7,636 shares in the company, valued at approximately $148,520.20. The trade was a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.23% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. CX Institutional increased its stake in shares of Healthpeak Properties by 6.1% in the second quarter. CX Institutional now owns 11,003 shares of the real estate investment trust’s stock worth $235,000 after purchasing an additional 633 shares in the last quarter. Fiduciary Trust Co boosted its stake in shares of Healthpeak Properties by 4.9% in the third quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust’s stock worth $264,000 after acquiring an additional 644 shares during the period. Patton Fund Management Inc. grew its position in shares of Healthpeak Properties by 5.2% during the fourth quarter. Patton Fund Management Inc. now owns 13,002 shares of the real estate investment trust’s stock worth $209,000 after purchasing an additional 648 shares in the last quarter. Quadrant Capital Group LLC raised its stake in Healthpeak Properties by 1.9% during the 3rd quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust’s stock valued at $721,000 after purchasing an additional 718 shares during the period. Finally, Quantum Portfolio Management LLC raised its stake in Healthpeak Properties by 2.5% during the 1st quarter. Quantum Portfolio Management LLC now owns 29,372 shares of the real estate investment trust’s stock valued at $483,000 after purchasing an additional 728 shares during the period. Institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.